Old Web
English
Sign In
Acemap
>
authorDetail
>
Melvin Lafeber
Melvin Lafeber
Erasmus University Rotterdam
Medicine
Intensive care medicine
Risk assessment
molecular targets
Surgery
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
No association between use of ACE inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study.
2021
British Journal of Clinical Pharmacology
Roos S G Sablerolles
Freija E F Hogenhuis
Melvin Lafeber
Bob P A van de Loo
Sander D. Borgsteede
Eric Boersma
Jorie Versmissen
Hugo van der Kuy
Show All
Source
Cite
Save
Citations (2)
Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming
2021
medRxiv
Roos S G Sablerolles
Wim J. R. Rietdijk
Abraham Goorhuis
D. F. Postma
Leo G. Visser
Daryl Geers
Katharina S. Schmitz
H.M. Garcia Garrido
M. Koopmans
Virgil A S H Dalm
Neeltje A. Kootstra
Anke Huckriede
Melvin Lafeber
D. van Baarle
Corine H. GeurtsvanKessel
R. de Vries
P.H.M. van der Kuy
Show All
Source
Cite
Save
Citations (0)
[Medicines: what has the last decade given us and what can we expect in the coming 10 years?]
2020
Nederlands Tijdschrift voor Geneeskunde
Melvin Lafeber
Rafke Schoffelen
Rebecca J Verheggen
Noortje van Herwaarden
Jaap ten Oever
Kees Kramers
Show All
Source
Cite
Save
Citations (0)
COvid MEdicaTion (COMET) study: protocol for a cohort study.
2020
European Journal of Hospital Pharmacy-Science and Practice
Roos S G Sablerolles
Freija E F Hogenhuis
Melvin Lafeber
Bob P A van de Loo
Sander D. Borgsteede
Eric Boersma
Jorie Versmissen
Hugo van der Kuy
Show All
Source
Cite
Save
Citations (3)
1